Global Gene Editing Market Size, Status and Forecast 2019-2025

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Gene Editing Revenue
• 1.4 Market by Type
  • 1.4.1 Global Gene Editing Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Zinc finger nucleases (ZFNs)
  • 1.4.3 Transcription Activator-Like Effector-based Nucleases (TALENs)
  • 1.4.4 CRISPR-Cas system
• 1.5 Market by Application
  • 1.5.1 Global Gene Editing Market Share by Application: 2020 VS 2026
  • 1.5.2 Biotechnology & Pharmaceutical Companies
  • 1.5.3 Academic & Government Research Institutes
  • 1.5.4 Contract Research Organizations
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Gene Editing Market Perspective (2015-2026)
• 2.2 Global Gene Editing Growth Trends by Regions
  • 2.2.1 Gene Editing Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Gene Editing Historic Market Share by Regions (2018-2019)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Competition Landscape by Key Players

• 3.1 Gene Editing Revenue by Players (2019-2020)
• 3.2 Gene Editing Key Players Head office and Area Served
• 3.3 Key Players Gene Editing Product/Solution/Service
• 3.4 Date of Enter into Gene Editing Market
• 3.5 Key Players Gene Editing Funding/Investment Analysis
• 3.6 Global Key Players Gene Editing Valuation & Market Capitalization
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Global Gene Editing Market Size by Type (2019-2026)

5 Global Gene Editing Market Size by Application (2019-2026)

6 North America

• 6.1 North America Gene Editing Market Forecast (2019-2026)
• 6.2 Gene Editing Key Players in North America (2019-2020)
• 6.3 North America Gene Editing Market Size by Type (2015-2020)
• 6.4 North America Gene Editing Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Gene Editing Market Forecast (2019-2026)
• 7.2 Gene Editing Key Players in Europe (2019-2020)
• 7.3 Europe Gene Editing Market Size by Type (2015-2020)
• 7.4 Europe Gene Editing Market Size by Application (2015-2020)

8 China

• 8.1 China Gene Editing Market Forecast (2019-2026)
• 8.2 Gene Editing Key Players in China (2019-2020)
• 8.3 China Gene Editing Market Size by Type (2015-2020)
• 8.4 China Gene Editing Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Gene Editing Market Forecast (2019-2026)
• 9.2 Gene Editing Key Players in Japan (2019-2020)
• 9.3 Japan Gene Editing Market Size by Type (2015-2020)
• 9.4 Japan Gene Editing Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Gene Editing Market Forecast (2019-2026)
• 10.2 Gene Editing Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Gene Editing Market Size by Type (2015-2020)
• 10.4 Southeast Asia Gene Editing Market Size by Application (2015-2020)

11 India

• 11.1 India Gene Editing Market Forecast (2019-2026)
• 11.2 Gene Editing Key Players in India (2019-2020)
• 11.3 India Gene Editing Market Size by Type (2015-2020)
• 11.4 India Gene Editing Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Gene Editing Market Forecast (2019-2026)
• 12.2 Gene Editing Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Gene Editing Market Size by Type (2015-2020)
• 12.4 Central & South America Gene Editing Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Thermo Fisher Scientific
  • 13.1.1 Thermo Fisher Scientific Company Details
  • 13.1.2 Thermo Fisher Scientific Business Overview
  • 13.1.3 Thermo Fisher Scientific Gene Editing Introduction
  • 13.1.4 Thermo Fisher Scientific Revenue in Gene Editing Business (2019-2020))
  • 13.1.5 Thermo Fisher Scientific Recent Development
• 13.2 Merck
  • 13.2.1 Merck Company Details
  • 13.2.2 Merck Business Overview
  • 13.2.3 Merck Gene Editing Introduction
  • 13.2.4 Merck Revenue in Gene Editing Business (2019-2020))
  • 13.2.5 Merck Recent Development
• 13.3 Horizo​​n Discovery
  • 13.3.1 Horizo​​n Discovery Company Details
  • 13.3.2 Horizo​​n Discovery Business Overview
  • 13.3.3 Horizo​​n Discovery Gene Editing Introduction
  • 13.3.4 Horizo​​n Discovery Revenue in Gene Editing Business (2019-2020))
  • 13.3.5 Horizo​​n Discovery Recent Development
• 13.4 Sangamo BioSciences
  • 13.4.1 Sangamo BioSciences Company Details
  • 13.4.2 Sangamo BioSciences Business Overview
  • 13.4.3 Sangamo BioSciences Gene Editing Introduction
  • 13.4.4 Sangamo BioSciences Revenue in Gene Editing Business (2019-2020))
  • 13.4.5 Sangamo BioSciences Recent Development
• 13.5 Integrated DNA Technologies
  • 13.5.1 Integrated DNA Technologies Company Details
  • 13.5.2 Integrated DNA Technologies Business Overview
  • 13.5.3 Integrated DNA Technologies Gene Editing Introduction
  • 13.5.4 Integrated DNA Technologies Revenue in Gene Editing Business (2019-2020))
  • 13.5.5 Integrated DNA Technologies Recent Development
• 13.6 Lonza
  • 13.6.1 Lonza Company Details
  • 13.6.2 Lonza Business Overview
  • 13.6.3 Lonza Gene Editing Introduction
  • 13.6.4 Lonza Revenue in Gene Editing Business (2019-2020))
  • 13.6.5 Lonza Recent Development
• 13.7 New England Biolabs
  • 13.7.1 New England Biolabs Company Details
  • 13.7.2 New England Biolabs Business Overview
  • 13.7.3 New England Biolabs Gene Editing Introduction
  • 13.7.4 New England Biolabs Revenue in Gene Editing Business (2019-2020))
  • 13.7.5 New England Biolabs Recent Development
• 13.8 OriGene Technologies
  • 13.8.1 OriGene Technologies Company Details
  • 13.8.2 OriGene Technologies Business Overview
  • 13.8.3 OriGene Technologies Gene Editing Introduction
  • 13.8.4 OriGene Technologies Revenue in Gene Editing Business (2019-2020))
  • 13.8.5 OriGene Technologies Recent Development
• 13.9 Transposagen Biopharmaceuticals
  • 13.9.1 Transposagen Biopharmaceuticals Company Details
  • 13.9.2 Transposagen Biopharmaceuticals Business Overview
  • 13.9.3 Transposagen Biopharmaceuticals Gene Editing Introduction
  • 13.9.4 Transposagen Biopharmaceuticals Revenue in Gene Editing Business (2019-2020))
  • 13.9.5 Transposagen Biopharmaceuticals Recent Development
• 13.10 Editas Medicine
  • 13.10.1 Editas Medicine Company Details
  • 13.10.2 Editas Medicine Business Overview
  • 13.10.3 Editas Medicine Gene Editing Introduction
  • 13.10.4 Editas Medicine Revenue in Gene Editing Business (2019-2020))
  • 13.10.5 Editas Medicine Recent Development
• 13.11 CRISPR Therapeutics
  • 10.11.1 CRISPR Therapeutics Company Details
  • 10.11.2 CRISPR Therapeutics Business Overview
  • 10.11.3 CRISPR Therapeutics Gene Editing Introduction
  • 10.11.4 CRISPR Therapeutics Revenue in Gene Editing Business (2019-2020))
  • 10.11.5 CRISPR Therapeutics Recent Development
• 13.12 RGen Solutions
  • 10.12.1 RGen Solutions Company Details
  • 10.12.2 RGen Solutions Business Overview
  • 10.12.3 RGen Solutions Gene Editing Introduction
  • 10.12.4 RGen Solutions Revenue in Gene Editing Business (2019-2020))
  • 10.12.5 RGen Solutions Recent Development
• 13.13 Sigma-Aldrich
  • 10.13.1 Sigma-Aldrich Company Details
  • 10.13.2 Sigma-Aldrich Business Overview
  • 10.13.3 Sigma-Aldrich Gene Editing Introduction
  • 10.13.4 Sigma-Aldrich Revenue in Gene Editing Business (2019-2020))
  • 10.13.5 Sigma-Aldrich Recent Development
• 13.14 GeneCopoeia
  • 10.14.1 GeneCopoeia Company Details
  • 10.14.2 GeneCopoeia Business Overview
  • 10.14.3 GeneCopoeia Gene Editing Introduction
  • 10.14.4 GeneCopoeia Revenue in Gene Editing Business (2019-2020))
  • 10.14.5 GeneCopoeia Recent Development
• 13.15 Genscript Biotech
  • 10.15.1 Genscript Biotech Company Details
  • 10.15.2 Genscript Biotech Business Overview
  • 10.15.3 Genscript Biotech Gene Editing Introduction
  • 10.15.4 Genscript Biotech Revenue in Gene Editing Business (2019-2020))
  • 10.15.5 Genscript Biotech Recent Development
• 13.16 OriGene Technologies
  • 10.16.1 OriGene Technologies Company Details
  • 10.16.2 OriGene Technologies Business Overview
  • 10.16.3 OriGene Technologies Gene Editing Introduction
  • 10.16.4 OriGene Technologies Revenue in Gene Editing Business (2019-2020))
  • 10.16.5 OriGene Technologies Recent Development
• 13.17 Agilent Technologies
  • 10.17.1 Agilent Technologies Company Details
  • 10.17.2 Agilent Technologies Business Overview
  • 10.17.3 Agilent Technologies Gene Editing Introduction
  • 10.17.4 Agilent Technologies Revenue in Gene Editing Business (2019-2020))
  • 10.17.5 Agilent Technologies Recent Development

14 Market Dynamics

• 14.1 Drivers
• 14.2 Challenges
• 14.3 Porter’s Five Forces Analysis
• 14.4 Market Ecosystem and Value Chain Analysis

15 Key Findings in This Report

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer